Diagnostic News and Research

RSS

Bedside screening tool can help diagnose acute aortic dissection

The most lethal and sudden cardiovascular event can be the toughest for doctors to diagnose. But a study by the University of Michigan Cardiovascular Center shows new guidelines are effective for determining who's most likely suffering from an aortic dissection, which is tearing in the lining of the body's largest blood vessel.

16 May 2011

Simple, minimal invasive technique could help detect early-stage lung cancer

A simple, minimally-invasive technique using cells from the interior of the nose could help clinicians detect lung cancer in its earliest - and most treatable - stages, according to a study conducted by researchers in Boston.

16 May 2011

NewGene develops breakthrough test for hereditary breast cancer

A new breakthrough test for hereditary breast cancer developed by UK-based NewGene could see thousands of women being diagnosed with the genetic condition in around half the usual time and at around half the cost of conventional test methods.

16 May 2011

Research roundup: Medicare costs in nursing homes; Docs reluctant to adopt EHRs; Health law to improve access to care

Medicare Expenditures Among Nursing Home Residents With Advanced Dementia -- Researchers followed 323 dementia patients in 22 nursing homes for up to 18 months and found that over an 18-month period, "total mean Medicare expenditures were $2303 per 90 days but were highly skewed; expenditures were less than $500 for 77.1% of the 90-day assessment periods and more than $12 000 for 5.5% of these periods.

13 May 2011

Corgenix third quarter revenues down 16.7% to $1,828,943

Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, today filed its third quarter Form 10-Q and reported its financial results.

13 May 2011

Researchers identify miRNA in blood serum of lung cancer patients

Researchers have identified characteristic patterns of molecules called microRNA in the blood of people with lung cancer that might reveal both the presence and aggressiveness of the disease, and perhaps who is at risk of developing it.

13 May 2011

Study: OVA1 blood test can accurately predict ovarian cancer in women with pelvic masses

A study published online ahead of print in the June 2011 edition of Obstetrics & Gynecology demonstrated that American College of Obstetrics and Gynecology guidelines for determining the likelihood that an ovarian mass is cancerous prior to surgery would accurately identify more women with ovarian cancer if the OVA1 blood test were used in place of the currently recommended CA 125 blood test.

From Quest Diagnostics 13 May 2011

Noninvasive stool test can detect pancreatic cancer

Pancreatic cancer has one of the highest mortality rates of any of the major cancers, and of the 43,000-plus Americans diagnosed with the disease each year, more than 94 percent die within five years of diagnosis. One reason for this high number of deaths is a lack of effective screening tools for catching the disease early.

12 May 2011

U-Systems to exhibit new version of somo•v automated breast ultrasound at SBI Meeting

U-Systems, the leader in automated breast ultrasound, will showcase significant upgrades to its somo•v Automated Breast Ultrasound System at the 10th Post Graduate Course of the Society of Breast Imaging Meeting, in San Antonio, May 18- 21.

12 May 2011

New genome-wide study identifies causes of serious childhood immune disorder

A new genomics study, led by the Center for Applied Genomics at The Children's Hospital of Philadelphia, sets the stage for the first predictive diagnostic test in a serious immunodeficiency disease in children. If the disorder, common variable immunodeficiency disease, can be diagnosed early, children may receive life-saving treatments before the disease can progress.

12 May 2011

Neogenix Oncology to receive European Patent for NEO-301 antibody for treatment of pancreatic cancer

Neogenix Oncology is pleased to announce that it will be granted a European Patent relating to its NEO-301 antibody, to take effect beginning September 23, 2011.

12 May 2011

ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard, the major cancer research and treatment center for the Rhône-Alpes region of France, and ImmunID Technologies SAS, a diagnostic company specialized in innovative immunomonitoring tests and services, today announced initiation of a Phase IIa clinical trial that will evaluate multiple combinations of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, and a chemotherapeutic agent, XELODA, in the treatment of metastatic breast cancer.

11 May 2011

AspirinWorks Test now available in greater Boston and surrounding area

A simple urine test that measures aspirin effect is now available in the greater Boston and surrounding area. The AspirinWorks Test is available to eastern Massachusetts and southern New Hampshire area doctors through Diagnostic Laboratory Medicine.

11 May 2011

Genentech submits vemurafenib NDA for BRAF V600 mutation-positive metastatic melanoma

Genentech, a member of the Roche Group, today announced that the company submitted a New Drug Application for vemurafenib to the U.S. Food and Drug Administration for people with BRAF V600 mutation-positive metastatic melanoma, and that Roche submitted a Marketing Authorization Application to the European Medicines Agency for vemurafenib in the same indication.

11 May 2011

Plexxikon seeks vemurafenib marketing approval from FDA and EMA for melanoma treatment

Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced that applications for market approval for vemurafenib for the treatment of metastatic melanoma have been submitted to the U.S. Food and Drug Administration and the European Medicines Agency.

11 May 2011

MTTI obtains exclusive license for novel fluorescence dyes from Massachusetts General Hospital

Molecular Targeting Technologies, Inc., announced that it has obtained an exclusive license from the Massachusetts General Hospital for novel fluorescence dyes developed by Scott Hilderbrand, Ph.D. Fangwei Shao, Ph.D., and Ralph Weissleder, Ph.D. M.D.

11 May 2011

China Sky One Medical first quarter total revenue decreases 1.9% to $28.4 million

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company in the People's Republic of China, today announced financial results for the first quarter of 2011.

11 May 2011

Researchers discover role of MAN2C1 protein in prostate cancer development

It's a disease affecting those closest to us - our fathers, brothers and sons. Prostate cancer impacts one in six men in Canada. Last year, roughly 24,600 men were diagnosed with the disease.

11 May 2011

Elekta to integrate cancer workflow and patient management tools into IBA's Proteus TK2 center

Elekta, a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders, will integrate cancer workflow and patient management tools into the Proteus TK2, a turnkey proton therapy center from Belgium-based Ion Beam Applications.

From Elekta 10 May 2011

Nexvax2- coeliac disease vaccine shows promising results in Phase I clinical trial

The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.

10 May 2011

Diagnostic News and Research

Bedside screening tool can help diagnose acute aortic dissection

Simple, minimal invasive technique could help detect early-stage lung cancer

NewGene develops breakthrough test for hereditary breast cancer

Research roundup: Medicare costs in nursing homes; Docs reluctant to adopt EHRs; Health law to improve access to care

Corgenix third quarter revenues down 16.7% to $1,828,943

Researchers identify miRNA in blood serum of lung cancer patients

Study: OVA1 blood test can accurately predict ovarian cancer in women with pelvic masses

Noninvasive stool test can detect pancreatic cancer

U-Systems to exhibit new version of somo•v automated breast ultrasound at SBI Meeting

New genome-wide study identifies causes of serious childhood immune disorder

Neogenix Oncology to receive European Patent for NEO-301 antibody for treatment of pancreatic cancer

ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer

AspirinWorks Test now available in greater Boston and surrounding area

Genentech submits vemurafenib NDA for BRAF V600 mutation-positive metastatic melanoma

Plexxikon seeks vemurafenib marketing approval from FDA and EMA for melanoma treatment

MTTI obtains exclusive license for novel fluorescence dyes from Massachusetts General Hospital

China Sky One Medical first quarter total revenue decreases 1.9% to $28.4 million

Researchers discover role of MAN2C1 protein in prostate cancer development

Elekta to integrate cancer workflow and patient management tools into IBA's Proteus TK2 center

Nexvax2- coeliac disease vaccine shows promising results in Phase I clinical trial

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News